Genetics, Neurology, Behavior, and Diet in Dementia : The Neuroscience of Dementia, Volume 2

個数:
電子版価格
¥32,928
  • 電子版あり

Genetics, Neurology, Behavior, and Diet in Dementia : The Neuroscience of Dementia, Volume 2

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 952 p.
  • 言語 ENG
  • 商品コード 9780128158685
  • DDC分類 616.831

Full Description

Genetics, Neurology, Behavior, and Diet in Dementia: The Neuroscience of Dementia, Volume 2 consolidates different fields of dementia research into a single book, covering a range of subjects, including Alzheimer's disease, Lewy body dementia, mixed dementia, vascular dementia, physical activity, risk factors, mortality, biomarkers, SPECT, CT, MRI, questionnaires, nutrition, sleep, delirium, hearing loss, agitation, aggression, delusions, anxiety, depression, hallucinations, psychosis, senile plaques, tau and amyloid-beta, neuroinflammation, and molecular biology. This foundational, comprehensive book assembles the latest understanding on all dementias and their common features in a single source. It is an invaluable resource for neuroscientists, neurologists, and anyone in the field.

Contents

Part I: Genetics, molecular and cellular biology

1. The neuron navigator 2 gene and Alzheimer's diseaseChun Xu, Brenda Bin Su, Stephanie Lozano and Kesheng Wang

2. Interlinking polymorphisms, estrogens, and Alzheimer diseaseLu Hua Chen, Leung Wing Chu and You-Qiang Song

3. Linking EEGs, Alzheimer disease, and the phosphatidylinositol-binding clathrin assembly protein (PICALM) geneNatalya Ponomareva, Tatiana Andreeva, Vitaly Fokin, Sergey Illarioshkin and Evgeny Rogaev

4. CD36 gene polymorphisms and Alzheimer's diseaseOmar Šerý, Nandu Goswami and Vladimir J. Balcar

5. Genetic contributions to sporadic frontotemporal dementiaJessie S. Carr, Daniel W. Sirkis and Jennifer S. Yokoyama

6. Clinical response to cholinesterase inhibitors in dementia: the role of CYP2D6 and APOE genetic polymorphismsLuís Felipe José Ravic de Miranda, Karina Braga Gomes and Paulo Caramelli

7. A1 and A2 purinergic receptor expression in dementiaJ. Mendiola-Precoma, L.C. Berumen, A. Rodríguez-Cruz and G. García-Alcocer

8. Molecular aspects of metallothioneins in dementiasGemma Comes, Anna Escrig, Yasmina Manso, Olaya Fernández-Gayol, Paula Sanchis, Amalia Molinero, Mercedes Giralt, Javier Carrasco and Juan Hidalgo

9. Implication of microRNAs in Alzheimer's disease pathogenesisKatarzyn Marta Zoltowska, Katarzyna Laskowska-Kaszub, Siranjeevi Nagaraj and Urszula Wojda

10. Role of cellular oxidative stress in dementiaGiovanna Galliciotti, Antonella De Jaco, Diego Sepulveda-Falla, Emanuela D'Acunto and Elena Miranda

11. Toward an integrative understanding of the neuroinflammatory molecular milieu in Alzheimer disease neurodegenerationJuan M. Zolezzi, Paulina Villaseca and Nibaldo C. Inestrosa

12. Wnt signaling and dementiaCarolina Alquezár and Ángeles Martín-Requero

13. Linkage of atypical protein kinase C to Alzheimer diseaseRobert V. Farese and Mini P. Sajan

14. Linking histone deacetylases and phosphodiesterase 5 in novel treatments for Alzheimer's diseaseAna Garcia-Osta and Mar Cuadrado-Tejedor

15. Nuclear factor erythroid 2-related factor 2 in Alzheimer's diseaseKelsey E. Murphy and Joshua J. Park

16. Implications of alpha- and beta-secretase expression and function in Alzheimer's diseaseSven Reinhardt and Kristina Endres

17. Methylation analysis of DNA in Alzheimer's diseaseFabio Coppedè

18. The signalosome malfunctions in age-associated neuropathologiesRicardo Puertas-Avendaño, David Quinto-Alemany, Miriam González-Gómez and Raquel Marin

19. FAM3C in Alzheimer's disease: a risk-related molecule and potential therapeutic targetMasaki Nishimura, Naoki Watanabe, Emi Hibino, Masaki Nakano, Yachiyo Mitsuishi, Lei Liu and Takuma Sugi

20. Amylin and amylin receptors in Alzheimer's diseaseWen Fu and Jack H. Jhamandas

21. Mammalian target of rapamycin complexes: regulation and Alzheimer's diseaseHenry Querfurth and Han-Kyu Lee

22. Mammalian target of rapamycin complexes: protein synthesis and autophagy, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal dementiaHenry Querfurth and Han-Kyu Lee

23. Linking CD200 in brains and dementia: molecular aspects of neuroinflammationDouglas Gordon Walker

Part II: Neurological, physiological and imaging

24. Hippocampal atrophy associated with dementia risk factors and dementiaHiroshi Yao, Yuko Araki, Fumio Yamashita, Makoto Sasaki and Manabu Hashimoto

25. Inflammation and insulin resistance in Alzheimer's disease: partners in crimeYuval Nash and Dan Frenke

26. Brain susceptibility to hypoxia/hypoxemia and metabolic dysfunction in Alzheimer's disease: insights from animal and in vitro modelsVito Antonio Baldassarro, Andrea Bighinati, Michele Sannia, Luciana Giardino and Laura Calzà

27. Neuropeptides and neurolipids: what they are and how they relate to Alzheimer's diseaseIván Manuel, Laura Lombardero, Alberto Llorente-Ovejero and Rafael Rodríguez-Puertas

28. Neurotransmitter receptors in Alzheimer's disease: from glutamatergic to cholinergic receptorsLaura Lombardero, Alberto Llorente-Ovejero, Iván Manuel and Rafael Rodríguez-Puertas

29. Aβ42-α7-like nicotinic acetylcholine receptors and Alzheimer's diseaseHoau-Yan Wang and Amber Khan

30. Synaptosomal bioenergetic defects in Alzheimer's diseasePamela V. Martino Adami and Laura Morelli

31. Limitations of amyloid imaging in Alzheimer's diseaseDavid Weidman

32. Linking gradient echo plural contrast imaging metrics of tissue microstructure with Alzheimer diseaseDmitriy A. Yablonskiy, Tammie L. Benzinger and John C. Morris

33. Hypertensive disorders during pregnancy and later dementia: is there a connection?Ellika Andolf

34. Unraveling the contributions of sleep dysfunction to Alzheimer's diseaseElie Gottlieb, Natalie A. Grima, Mark Howard, Amy Brodtmann and Matthew P. Pase

Part III: Behaviour and psychopathology

35. Overview of behaviors in dementiaDorothy M. Grillo and Rachel Anderson

36. Delirium superimposed on dementia: a clinical challenge from diagnosis to treatmentMorandi Alessandro, Pozzi Christian, Grossi Eleonora and Bellelli Giuseppe

37. Self-consciousness deficits in dementiaEva M. Arroyo-Anlló and Roger Gil

38. Attentional impairments to novel images in dementiaCelina S. Liu, Michael Rosen, Nathan Herrmann and Krista L. Lanctôt

39. Frontal lobe syndrome and dementiasPetronilla Battista, Chiara Griseta, Rosa Capozzo, Madia Lozupone, Rodolfo Sardone, Francesco Panza and Giancarlo Logroscino

40. The stigma of dementiaAlbert Aboseif and Benjamin K.P. Woo

41. Delusions in dementiasMadia Lozupone, Maddalena La Montagna, Antonello Bellomo, Petronilla Battista, Davide Seripa, Antonio Daniele, Antonio Greco, Onofrio Resta, Giancarlo Logroscino and Francesco Panza

42. Linking motor speech function and dementiaMatthew L. Poole and Adam P. Vogel

43. Spatial navigation and Alzheimer's diseaseLaura E. Berkowitz, Ryan E. Harvey and Benjamin J. Clark

44. Violence and dementiaG. Cipriani, S. Danti, A. Nuti, L. Picchi and M. Di Fiorino

45. Factors contributing to protection and vulnerability in dementia caregiversFan Zhang, Sheung-Tak Cheng and Manuel Gonçalves-Pereira

Part IV: Diet, nutrition and environment

46. Nutritional status of dementia and management using dietary taurine supplementationMi Ae Bae and Kyung Ja Chang

47. Selenium and Alzheimer's diseaseAdriana Gisele Hertzog da Silva Leme and Barbara R. Cardoso

48. Linking adiponectin and obesity in dementiaMa1gorzata Bednarska-Makaruk

49. The impact of the gut microbiome in Alzheimer's disease: cause or consequence?Malena dos Santos Guilherme and Kristina Endres

50. (-)-Epigallocatechin-3-gallate and Alzheimer's diseaseLaura Xicota and Rafael de la Torre

51. Lead, cadmium and Alzheimer's diseaseKelly M. Bakulski, Howard Hu and Sung Kyun Park

Part V: Models and modelling in dementia

52. Alzheimer model 5xfad mice and applications to dementia: transgenic mouse models, a focus on neuroinflammation, microglia, and food-derived componentsTatsuhiro Ayabe and Yasuhisa Ano

53. Use of 192 IgG-saporin as a model of dementia and its applicationJ.W. Chang and Y.S. Park

54. Amyloid beta 1e42-induced animal model of dementia: a reviewJosiane Budni and Jade de Oliveira

55. Resources for the neuroscience of dementiaRajkumar Rajendram and Victor R. Preedy

最近チェックした商品